BACKGROUND: Dobutamine stress echocardiography (DSE) is an established method of detecting myocardial ischemia. Its diagnostic accuracy solely depends on wall motion assessment. Clear visibility of the left ventricular endocardium is essential for reliable assessment of a wall motion abnormality. However, incremental benefits of contrast DSE for the detection of coronary artery disease (CAD) have not been demonstrated in overweight or obese patients. OBJECTIVES: The purpose of the present study was to test the incremental benefits of contrast DSE in detecting CAD in overweight or obese patients. METHODS: Sixty-two overweight or obese patients (body mass index 26 kg/m(2) to 33 kg/m(2)) underwent DSE with or without contrast and coronary angiography. Contrast-enhanced images were achieved at rest and during peak DSE after administration of SonoVue (Bracco Diagnostics Inc, Italy) or Optison (Mallinckrodt, USA). The endocardial border resolution for each myocardial segment was graded as 0, 1 or 2. A total of 992 segments from 62 subjects were analyzed. The results of DSE with or without contrast were compared with the findings on angiography. RESULTS: The differences in the score grading between the two groups with or without contrast, at rest and during peak DSE were statistically significant (P<0.001). The sensitivity, specificity and accuracy of contrast DSE in detecting CAD, compared with the studies without contrast, were improved (82% versus 70%, 78% versus 67% and 81% versus 69%, respectively). CONCLUSIONS: SonoVue and Optison can enhance left ventricular endocardial border delineation in overweight or obese patients, optimizing the evaluation of wall motion both at rest and during peak stress. This increases the diagnostic value of DSE in detecting CAD.
BACKGROUND:Dobutamine stress echocardiography (DSE) is an established method of detecting myocardial ischemia. Its diagnostic accuracy solely depends on wall motion assessment. Clear visibility of the left ventricular endocardium is essential for reliable assessment of a wall motion abnormality. However, incremental benefits of contrast DSE for the detection of coronary artery disease (CAD) have not been demonstrated in overweight or obesepatients. OBJECTIVES: The purpose of the present study was to test the incremental benefits of contrast DSE in detecting CAD in overweight or obesepatients. METHODS: Sixty-two overweight or obesepatients (body mass index 26 kg/m(2) to 33 kg/m(2)) underwent DSE with or without contrast and coronary angiography. Contrast-enhanced images were achieved at rest and during peak DSE after administration of SonoVue (Bracco Diagnostics Inc, Italy) or Optison (Mallinckrodt, USA). The endocardial border resolution for each myocardial segment was graded as 0, 1 or 2. A total of 992 segments from 62 subjects were analyzed. The results of DSE with or without contrast were compared with the findings on angiography. RESULTS: The differences in the score grading between the two groups with or without contrast, at rest and during peak DSE were statistically significant (P<0.001). The sensitivity, specificity and accuracy of contrast DSE in detecting CAD, compared with the studies without contrast, were improved (82% versus 70%, 78% versus 67% and 81% versus 69%, respectively). CONCLUSIONS: SonoVue and Optison can enhance left ventricular endocardial border delineation in overweight or obesepatients, optimizing the evaluation of wall motion both at rest and during peak stress. This increases the diagnostic value of DSE in detecting CAD.
Authors: R Senior; O Andersson; K Caidahl; P Carlens; M C Herregods; R Jenni; A Kenny; A Melcher; J Svedenhag; J L Vanoverschelde; B Wandt; B R Widgren; G Williams; P Guerret; K la Rosee ; L Agati; G Bezante Journal: Echocardiography Date: 2000-11 Impact factor: 1.724
Authors: M S Dolan; K Riad; A El-Shafei; S Puri; K Tamirisa; M Bierig; J St Vrain; L McKinney; E Havens; K Habermehl; L Pyatt; M Kern; A J Labovitz Journal: Am Heart J Date: 2001-11 Impact factor: 4.749
Authors: Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani Journal: Circulation Date: 2002-01-29 Impact factor: 29.690
Authors: Marta Rizzo; Maria Concetta Robertina Vono; Loira Toncelli; Patricia Peçagna; Paolo Manetti; Laura Stefani; Giorgio Galanti Journal: Eur J Echocardiogr Date: 2005-01
Authors: Jonathan Timperley; Andrew R J Mitchell; Helene Thibault; Intisar H Mirza; Harald Becher Journal: J Am Soc Echocardiogr Date: 2005-02 Impact factor: 5.251
Authors: S L Mulvagh; A N DeMaria; S B Feinstein; P N Burns; S Kaul; J G Miller; M Monaghan; T R Porter; L J Shaw; F S Villanueva Journal: J Am Soc Echocardiogr Date: 2000-04 Impact factor: 5.251
Authors: Anthony E DeCicco; Alexis B Sokil; Gregary D Marhefka; Kirk Reist; Christopher L Hansen Journal: J Nucl Cardiol Date: 2014-11-06 Impact factor: 5.952
Authors: Tiffany M Powell-Wiley; Paul Poirier; Lora E Burke; Jean-Pierre Després; Penny Gordon-Larsen; Carl J Lavie; Scott A Lear; Chiadi E Ndumele; Ian J Neeland; Prashanthan Sanders; Marie-Pierre St-Onge Journal: Circulation Date: 2021-04-22 Impact factor: 29.690
Authors: Michele Murphy; Siva Krothapalli; Jose Cuellar; Somsupha Kanjanauthai; Brian Heeke; Pallavi S Gomadam; Avirup Guha; Vernon A Barnes; Sheldon E Litwin; Gyanendra K Sharma Journal: J Obes Date: 2014-08-31